Role of myeloablative therapy in improved outcome for high risk neuroblastoma: Review of recent children's cancer group results
- 31 December 1995
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 31 (4), 572-575
- https://doi.org/10.1016/0959-8049(95)00015-b
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Gene Marking and Autologous Bone Marrow TransplantationAnnals of the New York Academy of Sciences, 1994
- Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study.Journal of Clinical Oncology, 1993
- Treatment of High-Risk Solid Tumors of Childhood with Intensive Therapy and Autologous Bone Marrow TransplantationPediatric Clinics of North America, 1991
- Prognostic Value of Immunocytologic Detection of Bone Marrow Metastases in NeuroblastomaThe New England Journal of Medicine, 1991
- Prognostic value of histopathology in advanced neuroblastoma: A report from the Childrens Cancer Study GroupHuman Pathology, 1988
- Metastatic interstitial pneumonitis after autologous bone marrow transplantation: A consequence of reinjection of malignant cells?Cancer, 1986
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasThe New England Journal of Medicine, 1985
- Histopathologic Prognostic Factors in Neuroblastic Tumors: Definition of Subtypes of Ganglioneuroblastoma and an Age-Linked Classification of NeuroblastomasJNCI Journal of the National Cancer Institute, 1984
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958